UNIGE document Scientific Article
previous document  unige:45950  next document
add to browser collection

Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria

Zufferey, Pascal
Ghosn, Jacqueline
Ciurea, Adrian
Aubry-Rozier, Bérengère
So, Alexander K
Published in Rheumatology international. 2015, vol. 35, no. 2, p. 295-302
Abstract To compare the impact of meeting specific classification criteria [modified New York (mNY), European Spondyloarthropathy Study Group (ESSG), and Assessment of SpondyloArthritis international Society (ASAS) criteria] on anti-tumor necrosis factor (anti-TNF) drug retention, and to determine predictive factors of better drug survival. All patients fulfilling the ESSG criteria for axial spondyloarthritis (SpA) with available data on the axial ASAS and mNY criteria, and who had received at least one anti-TNF treatment were retrospectively retrieved in a single academic institution in Switzerland. Drug retention was computed using survival analysis (Kaplan-Meier), adjusted for potential confounders. Of the 137 patients classified as having axial SpA using the ESSG criteria, 112 also met the ASAS axial SpA criteria, and 77 fulfilled the mNY criteria. Drug retention rates at 12 and 24 months for the first biologic therapy were not significantly different between the diagnostic groups. Only the small ASAS non-classified axial SpA group (25 patients) showed a nonsignificant trend toward shorter drug survival. Elevated CRP level, but not the presence of bone marrow edema on magnetic resonance imaging (MRI) scans, was associated with significantly better drug retention (OR 7.9, ICR 4-14). In this cohort, anti-TNF drug survival was independent of the classification criteria. Elevated CRP level, but not positive MRI, was associated with better drug retention.
PMID: 25070142
Full text
Article (Published version) (223 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Mécanisme de l'inflammation articulaire (44)
(ISO format)
ZUFFEREY, Pascal et al. Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria. In: Rheumatology international, 2015, vol. 35, n° 2, p. 295-302. doi: 10.1007/s00296-014-3094-z https://archive-ouverte.unige.ch/unige:45950

465 hits

0 download


Deposited on : 2015-01-28

Export document
Format :
Citation style :